Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Gastrointestinal 5Lymphoid 4Other hematologic neoplasm 2Endocrine 2Sarcoma 1Plasma cell 1Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 13110Triple Negative Breast Neoplasms 1145Neoplasms 748Ovarian Neoplasms 676Neoplasm Metastasis 588Lung Neoplasms 581Colorectal Neoplasms 576Prostatic Neoplasms 559Carcinoma, Non-Small-Cell Lung 533Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 349Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 265Head and Neck Neoplasms 265Endometrial Neoplasms 254Carcinoma, Renal Cell 215Sarcoma 202Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 190Lymphedema 190Breast Carcinoma In Situ 189Esophageal Neoplasms 188Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Breast Cancer Female 148

Interventions

Creatine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscular Atrophy × Breast × Clear all
NCT04207359 2023-07-25

Effects of Creatine Supplementation in Breast Cancer Survivors

The University of Texas Health Science Center at San Antonio

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscular Atrophy, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡